Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dai, Qiang | - |
dc.contributor.author | Singleton, Kenneth J. | - |
dc.date.accessioned | 2008-05-29T19:13:26Z | - |
dc.date.available | 2008-05-29T19:13:26Z | - |
dc.date.issued | 1998-10-27 | - |
dc.identifier.uri | http://hdl.handle.net/2451/27081 | - |
dc.description.abstract | In this paper, we explore the features of affine term structure models that are empirically important for explaining the joint distribution of yields on short and long-term interest rate swaps. We begin by showing that the family of N-factor affine models can be classified into N+1 non-nested sub-families of models. For each sub-family, we derive a maximal model with the property that every admissible member of this family is equivalent to or a nested special case of our maximal model. Second, using our classification scheme and maximal models, we show that many of the three-factor models in the literature impose potentially strong over-identifying restrictions on the joint distribution of short- and long-term rates. Third, we compute simulated method-of-moments estimates for several members of one of the four branches of three-factor models, and test the over-identifying restrictions implied by these models. We conclude that many of the extant affine models in the literature fail to describe important features of the distribution of long- and short- term rates. The source of the model misspecification is shown to be overly strong restrictions on the correlations among the state variables. Relaxing these restrictions leads to a model that passes several goodness-of-fit tests over our sample period. | en |
dc.language.iso | en_US | en |
dc.relation.ispartofseries | FIN-98-083 | en |
dc.title | Specification Analysis of Affine Term Structure Models | en |
dc.type | Working Paper | en |
Appears in Collections: | Finance Working Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
wpa98083.pdf | 2.08 MB | Adobe PDF | View/Open |
Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.